Kirkeby Cell Therapy APS

CVR 38650165 · Private limited company (ApS) · Active · Low risk

Kirkeby Cell Therapy APS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 1.5m and a net result of DKK -20k. CEO: Agnete Kirkeby.

Bankruptcy risk for Kirkeby Cell Therapy APS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 6% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Negative equityNo · bankruptcy rate 5.1%0.58×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38650165
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
c/o Agnete Kirkeby, Bøgehøj 17
2900 Hellerup
Municipality
Gentofte
Industry
Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Share capital
DKK 40k
Auditor
BUUS JENSEN, Statsautoriserede revisorer
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 9
Missing annual reportNo
Negative equityNo
Equity ratio98.9%
Current ratio8,799%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 26kDKK 60k
Net profitDKK -20kDKK 111k
EquityDKK 1.5mDKK 1.7m
Total assetsDKK 1.6mDKK 1.7m
CashDKK 906k–
Short-term debtDKK 18k–
Tax owedDKK 0–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · BUUS JENSEN, Statsautoriserede revisorer.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025163
1 Jan 2024 – 31 Dec 2024161
1 Jan 2023 – 31 Dec 202329
1 Jan 2022 – 31 Dec 2022145
1 Jan 2021 – 31 Dec 2021168
1 Jan 2020 – 31 Dec 2020186 Late
1 Jan 2019 – 31 Dec 2019183
1 Jan 2018 – 31 Dec 2018150
15 May 2017 – 31 Dec 201715

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOAgnete KirkebyCurrent
Owner (100%)Agnete KirkebyCurrent
FounderAgnete KirkebyCurrent

Address history (1 moves)

c/o Agnete Kirkeby, Bøgehøj 17, 2900 Hellerup
c/o Agnete Kirkeby, Øresund Parkvej 17, st. th, 2300 København S

Former names

Kirkeby Cell Therapy APS – now
Kirkeby Cell Therapy IVS –
Kirkeby Cell Therapey IVS –

Similar companies in Gentofte

Questions and answers about Kirkeby Cell Therapy APS

Has Kirkeby Cell Therapy APS gone bankrupt?

No, Kirkeby Cell Therapy APS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Kirkeby Cell Therapy APS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of Kirkeby Cell Therapy APS?

Agnete Kirkeby is the CEO of Kirkeby Cell Therapy APS.

Who is the auditor of Kirkeby Cell Therapy APS?

Kirkeby Cell Therapy APS most recently used BUUS JENSEN, Statsautoriserede revisorer.

When was Kirkeby Cell Therapy APS founded?

Kirkeby Cell Therapy APS was founded on 15 May 2017.

What is the equity of Kirkeby Cell Therapy APS?

Equity was DKK 1.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.